Danaher Corp. engages in the design, manufacture, and marketing of professional, medical, industrial, and commercial products and services. The company is headquartered in Washington, Washington Dc and currently employs 61,000 full-time employees. The firm operates through three segments: Biotechnology, Life Sciences and Diagnostics. The Biotechnology segment includes the bioprocessing and discovery and medical businesses and offers a broad range of equipment, consumables and services that are primarily used by customers to advance and accelerate the research, development, manufacture and delivery of biological medicines. The Life Sciences segment offers a broad range of instruments, consumables, services and software that are primarily used by customers to study the basic building blocks of life, including deoxyribonucleic acid (DNA) and ribonucleic acid (RNA), nucleic acid, proteins, metabolites and cells. The Diagnostics segment offers clinical instruments, consumables, software and services that hospitals, physicians’ offices, reference laboratories and other critical care settings use to diagnose disease and make treatment decisions.
Financials in millions USD. Fiscal year is February - January.
Breakdown
TTM
03/27/2026
12/31/2025
09/26/2025
06/27/2025
03/28/2025
Revenue
24,778
5,951
6,838
6,053
5,936
5,741
Revenue Growth (YoY)
4%
4%
5%
4%
3%
-1%
Cost of Revenue
10,161
2,360
2,858
2,530
2,413
2,215
Gross Profit
14,617
3,591
3,980
3,523
3,523
3,526
Selling, General & Admin
7,704
1,860
2,026
1,890
1,928
1,858
Research & Development
1,606
387
438
378
403
379
Operating Expenses
9,310
2,247
2,464
2,268
2,331
2,237
Other Non Operating Income (Expenses)
19
4
12
1
2
2
Pretax Income
4,339
1,235
1,373
1,076
655
1,129
Income Tax Expense
664
206
190
168
100
175
Net Income
3,689
1,029
1,197
908
555
954
Net Income Growth
-2%
8%
10%
11%
-39%
-12%
Shares Outstanding (Diluted)
711.2
711.2
710.7
713.7
719.1
720.8
Shares Change (YoY)
-1%
-1%
-2%
-2%
-3%
-4%
EPS (Diluted)
5.18
1.45
1.68
1.27
0.77
1.32
EPS Growth
-1%
10%
13%
13%
-37%
-9%
Free Cash Flow
5,291
1,085
1,746
1,370
1,090
1,054
Free Cash Flow Per Share
--
--
--
--
--
--
Gross Margin
58.99%
60.34%
58.2%
58.2%
59.34%
61.41%
Operating Margin
21.41%
22.58%
22.17%
20.73%
20.08%
22.45%
Profit Margin
14.88%
17.29%
17.5%
15%
9.34%
16.61%
Free Cash Flow Margin
21.35%
18.23%
25.53%
22.63%
18.36%
18.35%
EBITDA
7,790
1,971
2,139
1,877
1,803
1,880
EBITDA Margin
31.43%
33.12%
31.28%
31%
30.37%
32.74%
D&A For EBITDA
2,483
627
623
622
611
591
EBIT
5,307
1,344
1,516
1,255
1,192
1,289
EBIT Margin
21.41%
22.58%
22.17%
20.73%
20.08%
22.45%
Effective Tax Rate
15.3%
16.68%
13.83%
15.61%
15.26%
15.5%
Follow-Up Questions
What are Danaher Corp's key financial statements?
According to the latest financial statement (Form-10K), Danaher Corp has a total asset of $0, Net loss of $0
What are the key financial ratios for DHR?
Danaher Corp's Current ratio is 0, has a Net margin is 0, sales per share of $0.
How is Danaher Corp's revenue broken down by segment or geography?
Danaher Corp largest revenue segment is Other, at a revenue of -4,651,000,000 in the most earnings release.For geography, North America is the primary market for Danaher Corp, at a revenue of 10,356,000,000.
Is Danaher Corp profitable?
no, according to the latest financial statements, Danaher Corp has a net loss of $0